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Case Report
Retroperitoneal Giant Liposarcoma
Hyun Ho Han, Kyung Hwa Choi, Dong Suk Kim, Woo Jin Jeong, Seung Choul Yang, Seon Jung Jang1, 
Jun Jeong Choi1, Woong Kyu Han
Department of Urology, Urological Science Institute, 1Department of Pathology, Yonsei University Health System, Seoul, Korea
Retroperitoneal liposarcoma is an infrequent, locally aggressive malignancy. We report 
two cases of huge retroperitoneal liposarcomas. The presence of a palpable abdominal 
mass was a common symptom of the two patients. Preoperative imaging study showed 
huge retroperitoneal tumors. Both patients underwent complete surgical resections, 
and a negative microscopic margin was achieved in both cases. The histopathologic di-
agnosis was a well-differentiated retroperitoneal liposarcoma. Neither of the two pa-
tients developed a recurring tumor during the 1.5 years of follow-up.
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Liposarcoma is the most common tumor type of retro-
peritoneal soft tissue sarcomas [1]. Retroperitoneal lip-
osarcomas are difficult to detect early because the symp-
toms of these tumors appear late and are nonspecific; the 
tumors can thus grow slowly in the retroperitoneal space, 
reaching a considerable size before being diagnosed [2]. 
Case reports of retroperitoneal liposarcomas with a max-
imal diameter＞15 cm have often been made. Regardless 
of size, the treatment of choice for a huge retroperitoneal 
sarcoma is surgery. Complete resection of the tumor and 
a favorable histopathologic grade are positively associated 
with long-term disease-free survival. Compared with other 
retroperitoneal sarcoma subtypes, liposarcoma of this area 
shows a relatively good prognosis. Effects of chemotherapy 
and radiation therapy have also been reported. In some cas-
es, these treatments have been reported to be effective as 
an adjuvant therapy, but controversy over this point still 
exists. We experienced two cases of giant retroperitoneal 
liposarcomas treated at our medical institution. Here we 
discuss the histopathologic findings and surgical outcomes 
of these cases. We report our cases with a review of past 
studies.
CASE REPORTS
Case report 1
An 82-year-old man presented at our institution with a 
chief complaint of an abdominal mass and associated ab-
dominal discomfort. He had first noticed it 4 years before 
the consultation, and it was revealed as a lipomatous retro-
peritoneal tumor by computed tomography (CT) performed 
at a local clinic. The clinic referred the patient to us because 
the serial follow-up imaging study showed that the tumor 
had been growing. During the physical examination, we 
were able to palpate the large abdominal mass. We found 
no other specific abnormalities associated with it. Suspec- 
ting it to be a liposarcoma, we performed an abdominal CT 
scan and saw a huge abdominal mass lesion composed 
mainly of lipomatous tissues (Fig. 1A). All laboratory data 
were within normal ranges. We made a preoperative diag-
nosis of a retroperitoneal liposarcoma, and the patient was 
explored via laparotomy.
Intraoperatively, there was a mass occupying the ab-
dominopelvic cavity. Because the lesion involved the left 
kidney and adrenal gland, we performed a tumor resection 
en bloc with the left kidney and the adrenal gland. The sur-
gical specimen measured 30x30x8 cm and weighed 3,600 
g (Fig. 1B). The cut surface of the mass was multilobular 
and almost uniformly yellow. The histopathological diag-
nosis was a well-differentiated liposarcoma originating 
from the retroperitoneum (Fig. 1C).
No evidence of recurrence or metastasis was noted on the 
follow-up CT scans conducted 1.5 years after the operation.
Case report 2
A 64-year-old man presented with a known huge abdomi-
Korean J Urol 2010;51:579-582
580 Han et al
FIG. 2. (A) Computed tomography (CT) image showing a large fatty mass with an enhancing solid portion in the left renal subcapsular
area. The kidney shows sprayed. (B) The gross specimen consisting of the left kidney and attached soft tissue, weighing 2,120 g. On
bisection, a well-encapsulated, multilobulated, yellowish creamy white solid mass was noted, measuring 18x16x13 cm. Focal necrotic
areas are seen, making up 10% of the tumor volume. (C) Microscopic findings showing a well-differentiated liposarcoma and ma-
ture-appearing adipose tissue with scattered lipoblasts (H&E, x200).
nal mass. An ultrasound-guided biopsy had already been 
performed at another hospital, and a retroperitoneal lip-
osarcoma was reported. Because the patient had com-
plained of mild dyspnea and bowel habit changes, he was 
sent to our institution for further evaluation and treatment. 
An abdominal CT scan was performed for re-examination, 
demonstrating an 11.5x9x17.5 cm sized fatty mass with an 
enhanced solid portion located in the left renal subcapsular 
FIG. 1. (A) Computed tomography (CT) findings. The CT image 
shows a huge, fat-containing mass originating from the 
retroperitoneum. Encasement of the left kidney by the mass can 
be observed. (B) Gross findings. The tumor was a multilobulated, 
huge, mass-like lesion, measuring about 30x30x8 cm. Serial sec-
tions of the specimen revealed a homogeneously yellow colored 
fatty tissue without other significant solid portions. (C) 
Microscopic findings showing a well-differentiated liposarcoma, 
composed of mature adipocytes and a few scattered lipoblasts 
(H&E, x400).
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area (Fig. 2A). We assumed it was a retroperitoneal lip-
omatous tumor and decided on surgical exploration. The 
surgery revealed a huge retroperitoneal mass, measuring 
18 cm in maximal diameter. Because the tumor grossly en-
cased the left kidney, we also performed a nephrectomy for 
complete resection of the tumor. The final pathological re-
port confirmed a well-differentiated liposarcoma, and the 
resection margins were tumor-free (Fig. 2B, C). The post-
operative course was not significant, and the follow-up 
imaging study showed no evidence of tumor recurrence af-
ter 1.5 years.
DISCUSSION
The annual incidence of sarcoma is relatively low, compos-
ing approximately 0.8% of all newly diagnosed malignancies. 
Of these sarcomas, liposarcoma accounts for approx-
imately 20%, and about 13% of them originate from the 
retroperitoneum. Leiomyosarcoma and pleomorphic sub-
types are also common cases of retroperitoneal sarcomas. 
Retroperitoneal liposarcomas are then further classified 
by their histologic grades of cellular differentiation.
In most patients, definite symptoms are lacking, and the 
diagnosis is routinely made on the basis of CT scans of the 
abdomen and pelvis. Abdominal organ involvement and lo-
cal metastasis are relatively common [3].
Although controversy exists, adjuvant or neoadjuvant 
radiotherapy or chemotherapy do not have any survival 
benefits in retroperitoneal liposarcoma. Only surgical in-
tervention has been shown to improve overall survival, and 
the most important variable in outcome is the ability to 
completely resect the tumor, which often requires removal 
of the adjacent organs. In a previous study, the median sur-
vival of patients who underwent complete resection was 
103 months. Conversely, the median survival of patients 
undergoing incomplete resection was 18 months, which 
was no different from performing no resection at all [4].
Histopathologic grades of differentiation and tumor sub-
type also affect overall survival rates. Of the subtypes, the 
5-year survival rate of well-differentiated liposarcoma 
reaches 90%. By contrast, the survival rate of pleomorphic 
subtypes has been reported to be 50%. In addition, the sur-
vival rate has been reported to be 75% in de-differentiated 
cases and 60% in cases of the myxoid/round cell subtype 
[1,5].
Mortality associated with retroperitoneal sarcoma is 
usually due to its local recurrence. In a prospective study 
of 500 patients with retroperitoneal sarcoma, the median 
survival was significantly lower in a group with local re-
currence than in a group with only primary disease [4]. 
Although the rate of local recurrence was higher than for 
other sarcomas, meaningful long-term survival could be 
achieved with multiple re-operations for recurrent disease 
[6]. 
Because there are few clinical findings and specific labo-
ratory abnormalities, these tumors may grow to a large size 
without any symptoms. The literature shows that about 
20% of retroperitoneal sarcomas are＞10 cm at the time of 
diagnosis [4,7]. For example, Yol et al reported a retro-
peritoneal tumor weighing 42 kg [8].
The size of the tumor itself is not associated with surgical 
resectability and consequently does not affect survival. In 
a certain group of patients who underwent complete re-
section, however, a size＞10 cm and a high histologic grade 
could predict poorer treatment outcome.
As in the presenting cases, the tumors are usually large 
at the time of detection, which corresponds with the diffi-
culties of achieving complete surgical excision [9]. 
However, we could demonstrate complete tumor resection 
with a negative margin, whereas the reported negative mi-
croscopic margin rate in general was 74% in a past study 
[4]. That study also described the perioperative (30-day) 
mortality rate (4%), related to complications such as bleed-
ing, sepsis, and myocardial infarction. Neither of our pa-
tients had any serious perioperative or postoperative 
events. After 1.5 years, the patients underwent follow-up 
CT, and no tumor recurrence was detected. From this point, 
combined with the fact that we achieved negative surgical 
margins and the tumors were of a good histopathologic 
grade and subtype, we predict a low rate of local recurrence 
and good overall survival.
Complete resection is thus the most important compo-
nent of treatment, regardless of tumor size or adjacent or-
gan involvement. The resectability of the tumor and histo-
pathologic grades are associated with disease prognosis, 
and both factors are hard to elucidate before undergoing 
surgical intervention. Resections of contiguous organs are 
common and include en bloc resection of retroperitoneal or-
gans, including the kidney, adrenal gland, pancreas, 
spleen, and even vascular resection (inferior vena cava) if 
indicated [4].
Several retrospective studies have suggested that post-
operative radiotherapy may yield better outcomes than 
surgery alone, although other similarly designed studies 
revealed no advantage [10]. Randomized large-sized group 
trials are required to determine the benefit of adjuvant ra-
diotherapy after surgery.
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